IJN performs first TricValve procedure on tricuspid regurgitation in Asia | Healthcare Asia Magazine
, Malaysia
Photo courtesy of OrbusNeich

IJN performs first TricValve procedure on tricuspid regurgitation in Asia

The procedure is a breakthrough in treating leaking heart valves.

The Institut Jantung Negara (National Heart Institute/IJN) in Malaysia is the first hospital in Asia to perform the OrbusNeich TricValve Transcatheter Bicaval Valves procedure for patients suffering from tricuspid regurgitation or leaky heart valves.

It is a procedure where a bioprosthesis, called a dry stent-valve, is inserted via a preloaded delivery system. It was performed by the Heart Failure and Heart Transplant Team and Cardiology Department on 6 May.

IJN CEO Datuk Dr Aizai Azan Abdul Rahim has thanked the department for seeking out newer and more innovative methods of treatment.

“It’s no secret that IJN’s success has been built on the willingness of our staff to keep learning, exploring for new innovative treatments that can enhance our patients’ quality of life, and pushing the boundaries to be able to treat more patients who are deemed unsuitable for surgeries,” he said in an interview with the Malaysian Reserve.

The IJN Cardiology Department Head Dr. Shaiful Azmi Yahaya said the team first conducted the procedure on a 67-year-old woman who had long-standing hypertension and atrial fibrillation, which is an irregular heartbeat. He explained that the patient is doing very well three months post-procedure.

IJN Clinical Director Datuk Dr. Azmee Mohd Ghazi stated that a common surgical option for tricuspid valve regurgitation is an annuloplasty, wherein the ring around the valve in the heart is tightened.
“Unfortunately, in patients with severely dilated tricuspid annulus or with a prior pacemaker or other underlying conditions, they will not be suitable for such a procedure," he noted. “For such cases, it is important that we can offer a new innovative treatment like TricValve to help more patients alleviate their symptoms and improve their quality of life.”

The TricValve procedure is not for everyone as patients are required to undergo intensive investigations such as CT scans and coronary angiograms. 

The procedure is also not an outpatient treatment yet. Shaiful hoped that more insurance companies would consider this procedure as it may cost up to more than $24,125.46 (RM 100,000). 

Follow the links for more news on

Join Healthcare Asia Magazine community
Since you're here...

...there are many ways you can work with us to advertise your company and connect to your customers. Our team can help you dight and create an advertising campaign, in print and digital, on this website and in print magazine.

We can also organize a real life or digital event for you and find thought leader speakers as well as industry leaders, who could be your potential partners, to join the event. We also run some awards programmes which give you an opportunity to be recognized for your achievements during the year and you can join this as a participant or a sponsor.

Let us help you drive your business forward with a good partnership!


CHI accelerates the development and adoption of health tech firm innovations
The Centre for Healthcare Innovation invests $2.4m (US1.8m) to set a framework that can test the safety of market-ready innovations.
Catholic Medical Center trailblazing big data and AI adoption in Korean healthcare
Its flagship Seoul St. Mary’s Hospital leads the seamless integration of cutting-edge technology across CMC’s eight affiliate hospitals.
OUE Healthcare poised to capture foreign patient demand for specialist care services
The healthcare group recently partnered with three medical specialist groups including two leading respiratory and cardiothoracic surgery specialist practices.
iClaim boosts Thailand’s health insurance claims in 10 seconds
IT expert Piyawat Maneenual sets up a game-changing platform that allows data transfer from hospitals to insurance companies in real-time.